Location and level of Etk expression in neurons are associated with varied severity of traumatic brain injury

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Wu, John Chung Che ^a,b,c   Chen, Kai Yun ^c,d,e   Yu, Yu Wen ^d,e   Huang, Song Wei ^e   Shih, Hsiu Ming ^f   Chiu, Wen Ta ^g   Chiang, Yung Hsiao ^c,d,e   Shiau, Chia Yang ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b Taitung Christian Hospital   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d Graduate Institute of Cancer Biology and Drug Discovery   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^g Ministry of Health   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL ENDOTHELIAL TYROSINE KINASE; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; IMMUNOFLUORESCENCE TEST; INFLAMMATION; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRAUMATIC BRAIN INJURY; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BRAIN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; MALE; NERVE TISSUE PROTEINS; NEURONS; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; S100 PROTEINS; TRAUMA SEVERITY INDICES;

EID: 84862498489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039226     Document Type: Article

References (49)

1. Andriessen TM, Jacobs B, Vos PE, (2010) Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. Journal of cellular and molecular medicine 14: 2381-2392.
2. de KruijkJR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A, (2001) S-100B and neuron-specific enolase in serum of mild traumatic brain injury patients. A comparison with health controls. Acta Neurol Scand 103: 175-179.
3. Ingebrigtsen T, Romner B, (2003) Biochemical serum markers for brain damage: a short review with emphasis on clinical utility in mild head injury. Restor Neurol Neurosci 21: 171-176.
4. Lo TY, Jones PA, Minns RA, (2009) Pediatric brain trauma outcome prediction using paired serum levels of inflammatory mediators and brain-specific proteins. J Neurotrauma 26: 1479-1487.
5. Woertgen C, Rothoerl RD, Wiesmann M, Missler U, Brawanski A, (2002) Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir pp. 205-207.
6. Rothoerl RD, Brawanski A, Woertgen C, (2000) S-100B protein serum levels after controlled cortical impact injury in the rat. Acta Neurochir (Wien) 142: 199-203.
7. Geyer C, Ulrich A, Grafe G, Stach B, Till H, (2009) Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury. J Neurosurg Pediatr 4: 339-344.
8. Pelinka LE, Hertz H, Mauritz W, Harada N, Jafarmadar M, et al. (2005) Nonspecific increase of systemic neuron-specific enolase after trauma: clinical and experimental findings. Shock 24: 119-123.
9. Topolovec-Vranic J, Pollmann-Mudryj MA, Ouchterlony D, Klein D, Spence J, et al. (2011) The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. The Journal of trauma 71: S478-486.
10. Risdall JE, Menon DK, (2011) Traumatic brain injury. Philosophical transactions of the Royal Society of London Series B, Biological sciences 366: 241-250.
11. Zhu D, Wang Y, Singh I, Bell RD, Deane R, et al. (2010) Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. Blood 115: 4963-4972.
12. Chen KY, Wu CC, Chang CF, Chen YH, Chiu WT, et al. (2011) Suppression of Etk/Bmx Protects against Ischemic Brain Injury. Cell transplantation.
13. Xiong Y, Hall ED, (2009) Pharmacological evidence for a role of peroxynitrite in the pathophysiology of spinal cord injury. Experimental neurology 216: 105-114.
14. Deng Y, Thompson BM, Gao X, Hall ED, (2007) Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury. Experimental neurology 205: 154-165.
15. Xiong Y, Rabchevsky AG, Hall ED, (2007) Role of peroxynitrite in secondary oxidative damage after spinal cord injury. Journal of neurochemistry 100: 639-649.
16. Yamashima T, Oikawa S, (2009) The role of lysosomal rupture in neuronal death. Progress in neurobiology 89: 343-358.
17. Kilinc D, Gallo G, Barbee KA, (2009) Mechanical membrane injury induces axonal beading through localized activation of calpain. Experimental neurology 219: 553-561.
18. Deng-Bryant Y, Singh IN, Carrico KM, Hall ED, (2008) Neuroprotective effects of tempol, a catalytic scavenger of peroxynitrite-derived free radicals, in a mouse traumatic brain injury model. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism 28: 1114-1126.
19. Zhou P, Qian L, D'Aurelio M, Cho S, Wang G, et al. (2012) Prohibitin reduces mitochondrial free radical production and protects brain cells from different injury modalities. The Journal of neuroscience: the official journal of the Society for Neuroscience 32: 583-592.
20. Das A, Belagodu A, Reiter RJ, Ray SK, Banik NL, (2008) Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. Journal of pineal research 45: 117-124.
21. Samantaray S, Sribnick EA, Das A, Knaryan VH, Matzelle DD, et al. (2008) Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. Journal of pineal research 44: 348-357.
22. Sribnick EA, Matzelle DD, Ray SK, Banik NL, (2006) Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. Journal of neuroscience research 84: 1064-1075.
23. Cekic M, Johnson SJ, Bhatt VH, Stein DG, (2012) Progesterone treatment alters neurotrophin/proneurotrophin balance and receptor expression in rats with traumatic brain injury. Restorative neurology and neuroscience.
24. Kasahara Y, Taguchi A, Uno H, Nakano A, Nakagomi T, et al. (2010) Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia. Brain research 1340: 70-80.
25. Chen CC, Hung TH, Wang YH, Lin CW, Wang PY, et al. (2012) Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-kappaB Signaling after Experimental Traumatic Brain Injury. PloS one 7: e30294.
26. Ottens AK, Golden EC, Bustamante L, Hayes RL, Denslow ND, et al. (2008) Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry. Journal of neurochemistry 104: 1404-1414.
27. Zhang Z, Ottens AK, Sadasivan S, Kobeissy FH, Fang T, et al. (2007) Calpain-mediated collapsin response mediator protein-1, -2, and -4 proteolysis after neurotoxic and traumatic brain injury. Journal of neurotrauma 24: 460-472.
28. Mustafa AG, Wang JA, Carrico KM, Hall ED, (2011) Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury. Journal of neurochemistry 117: 579-588.
29. Thompson SN, Carrico KM, Mustafa AG, Bains M, Hall ED, (2010) A pharmacological analysis of the neuroprotective efficacy of the brain- and cell-permeable calpain inhibitor MDL-28170 in the mouse controlled cortical impact traumatic brain injury model. Journal of neurotrauma 27: 2233-2243.
30. Saatman KE, Creed J, Raghupathi R, (2010) Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics 7: 31-42.
31. Yu CG, Joshi A, Geddes JW, (2008) Intraspinal MDL28170 microinjection improves functional and pathological outcome following spinal cord injury. Journal of neurotrauma 25: 833-840.
32. Ai J, Liu E, Wang J, Chen Y, Yu J, et al. (2007) Calpain inhibitor MDL-28170 reduces the functional and structural deterioration of corpus callosum following fluid percussion injury. Journal of neurotrauma 24: 960-978.
33. Pineda JA, Lewis SB, Valadka AB, Papa L, Hannay HJ, et al. (2007) Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. Journal of neurotrauma 24: 354-366.
34. Siman R, Toraskar N, Dang A, McNeil E, McGarvey M, et al. (2009) A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. Journal of neurotrauma 26: 1867-1877.
35. Robinson D, He F, Pretlow T, Kung HJ, (1996) A tyrosine kinase profile of prostate carcinoma. Proc Natl Acad Sci U S A 93: 5958-5962.
36. Chen KY, Huang LM, Kung HJ, Ann DK, Shih HM, (2004) The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells. Oncogene 23: 1854-1862.
37. He Y, Luo Y, Tang S, Rajantie I, Salven P, et al. (2006) Critical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis. The Journal of clinical investigation 116: 2344-2355.
38. Jasielska M, Semkova I, Shi X, Schmidt K, Karagiannis D, et al. (2010) Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization. Investigative ophthalmology & visual science 51: 3874-3883.
39. Paavonen K, Ekman N, Wirzenius M, Rajantie I, Poutanen M, et al. (2004) Bmx tyrosine kinase transgene induces skin hyperplasia, inflammatory angiogenesis, and accelerated wound healing. Mol Biol Cell 15: 4226-4233.
40. Helmy A, Carpenter KL, Skepper JN, Kirkpatrick PJ, Pickard JD, et al. (2009) Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery. J Neurotrauma 26: 549-561.
41. Palmer CD, Mutch BE, Workman S, McDaid JP, Horwood NJ, et al. (2008) Bmx tyrosine kinase regulates TLR4-induced IL-6 production in human macrophages independently of p38 MAPK and NFkapp}B activity. Blood 111: 1781-1788.
42. Kleindienst A, Hesse F, Bullock MR, Buchfelder M, (2007) The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications. Prog Brain Res 161: 317-325.
43. Pelinka LE, Toegel E, Mauritz W, Redl H, (2003) Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 19: 195-200.
44. Gabbita SP, Scheff SW, Menard RM, Roberts K, Fugaccia I, et al. (2005) Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J Neurotrauma 22: 83-94.
45. Hergenroeder GW, Moore AN, McCoy JP, Jr., Samsel L, Ward NH, 3rd, et al (2010) Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 7: 19.
46. Honda M, Tsuruta R, Kaneko T, Kasaoka S, Yagi T, et al. (2010) Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. J Trauma 69: 104-109.
47. Gyorgy AB, Ling GS, Wingo DL, Walker J, Tong LC, et al. (2011) Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma.
48. Tran ND, Kim S, Vincent HK, Rodriguez A, Hinton DR, et al. (2010) Aquaporin-1-mediated cerebral edema following traumatic brain injury: effects of acidosis and corticosteroid administration. Journal of neurosurgery 112: 1095-1104.
49. Wang Y, Lin SZ, Chiou AL, Williams LR, Hoffer BJ, (1997) Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. The Journal of neuroscience: the official journal of the Society for Neuroscience 17: 4341-4348.